Literature DB >> 2414352

Heterogeneity of metachromatic cells in human nose: significance of mucosal mast cells.

H Otsuka, J Denburg, J Dolovich, D Hitch, P Lapp, R S Rajan, J Bienenstock, D Befus.   

Abstract

The distribution and abundance of histochemically and morphologically distinct subpopulations of metachromatic cells were investigated in nasal secretions and scrapings from patients with allergic rhinitis, as well as in nasal biopsy specimens from other patients. These analyses of the metachromatic cells demonstrate that basophils and two distinct mast cell populations are present in nasal specimens. One mast cell subpopulation was analogous to the atypical mucosal mast cell of the rat and human intestine, whereas the other cell population was similar to the typical connective tissue mast cell type. In nasal scrapings greater than 80% of the metachromatic cells was mast cells, almost exclusively of the atypical "mucosal" type. However, basophils were the predominant metachromatic cell type in nasal secretions, and atypical mast cells were more abundant than typical mast cells. Few basophils were observed in biopsy specimens, but mast cells were widely distributed in various anatomic compartments. Atypical mast cells outnumbered the typical type in the epithelium and lamina propria, whereas the reverse was true in the submucosa. When the number and type of metachromatic cell in scrapings were analyzed in relation to clinical findings, there was a significant correlation with severity of symptomatology and nasal swelling and pallor. Atypical "mucosal" mast cells were the major cell type in all specimens, from those with mild to those with severe clinical findings. When the distinct spectrum of responsiveness to antiallergic compounds of atypical mast cells is considered, these observations have important therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414352     DOI: 10.1016/0091-6749(85)90673-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease.

Authors:  P Goldsmith; B McGarity; A F Walls; M K Church; G H Millward-Sadler; D A Robertson
Journal:  Dig Dis Sci       Date:  1990-11       Impact factor: 3.199

Review 2.  Cytokine-induced human basophil/mast cell growth and differentiation in vitro.

Authors:  J A Denburg
Journal:  Springer Semin Immunopathol       Date:  1990

3.  Cellular characteristics of sputum from patients with asthma and chronic bronchitis.

Authors:  P G Gibson; A Girgis-Gabardo; M M Morris; S Mattoli; J M Kay; J Dolovich; J Denburg; F E Hargreave
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

4.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells.

Authors:  R Pawankar; M Okuda; H Yssel; K Okumura; C Ra
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  Essential role of the prosurvival bcl-2 homologue A1 in mast cell survival after allergic activation.

Authors:  Z Xiang; A A Ahmed; C Möller; K Nakayama; S Hatakeyama; G Nilsson
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

6.  Untargeted analysis of the airway proteomes of children with respiratory infections using mass spectrometry based proteomics.

Authors:  Charles J Sande; Martin Mutunga; Jacqueline Muteti; James A Berkley; D James Nokes; James Njunge
Journal:  Sci Rep       Date:  2018-09-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.